CellPhire Therapeutics is Drug Discovery in United States that focus on regenerative medicine business. Founded in 2005. They cover business area such as developer, cell stabilization technology, cellular material, advanced technological purpose, application, health care field, trauma, imaging, target drug delivery, regenerative medicine, clinical and research diagnostic reagent, physician, an adequate supply, bleeding casualty.
2005
( 19 years old in 2024 )
Regenerative Medicine
-
9430 Key West Avenue
Suite 250
Rockville, MD 20850
United States
Private
developercell stabilization technologycellular materialadvanced technological purposeapplicationhealth care fieldtraumaimagingtarget drug deliveryregenerative medicineclinical and research diagnostic reagentphysicianan adequate supplybleeding casualty
* We use standard office opening hours in near CellPhire Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
CellPhire Therapeutics is Drug Discovery business from United States that founded in 2005 (19 years old in 2024), CellPhire Therapeutics business is focusing on Regenerative Medicine.
CellPhire Therapeutics headquarter office and corporate office address is located in 9430 Key West Avenue Suite 250 Rockville, MD 20850 United States.
CellPhire Therapeutics was founded in United States.
In 2024, CellPhire Therapeutics is currently focus on regenerative medicine sector.
Above is snippet of Google Trends for "regenerative medicine" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with CellPhire Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
